Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Haiqun Jia Joel M. Gottesfeld |
| Publication date | May 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |